Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. - Wikidata - awgldk - TriplyDB

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

http://www.wikidata.org/entity/Q34343729

about

Antibodies as Mediators of Brain Pathology Update on biomarkers in neuromyelitis optica International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.Differential diagnosis of neuromyelitis optica spectrum disorders.AQP4 autoantibody assay performance in clinical laboratory service.Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.Demographic and clinical features of neuromyelitis optica: A review.Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.Neuromyelitis optica: an often forgotten cause of intractable nausea and vomiting.Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.Serological markers associated with neuromyelitis optica spectrum disorders in South India.Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu.Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.Neuromyelitis optica: a positive appraisal of seronegative cases.CNS inflammation other than multiple sclerosis: how likely is diagnosis?MOG antibody-related disorders: common features and uncommon presentations.Therapeutic options in neuromyelitis optica spectrum disorders.Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.A loss of sensation.Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion.

P2860

Q26780374-221CA0A4-8E0A-460F-86DE-36B734068B46 Q26799789-022CBD79-D23B-4A7A-A5F3-E117F0284CE8 Q26824579-7005154F-62B0-4919-AF08-482B64E714C1 Q28075974-DE6ACD32-E995-4A9D-AE6B-B81EC63C1F03 Q30676331-EDD35639-E776-449A-BAEE-AF59D93A996C Q30785267-32A0C668-A573-44BF-94F0-F0BD4EBAC62A Q30833332-C9720FE2-F6D4-4CD8-9884-914DB4955849 Q33567268-3E96BE1D-C0B6-4173-8B69-10889219F0D4 Q33591024-5151EF50-7A5B-47AE-A053-0962C2F6F955 Q33812063-19F3A452-078E-4528-B8E8-3E34A0D2E059 Q34368662-4A61E33E-0179-4B9E-9537-7C1898AE4BFE Q34431835-B45030B0-1DBB-416B-A88C-B78814C60EC1 Q34486841-96190285-6275-449B-AD9E-BC77724D20CA Q34545836-F3CE4825-C8AB-4E3E-B38D-726120E3237E Q35048235-4AE29653-D210-4E08-AFC3-5065C5D00689 Q35072715-8348A9EA-7FA6-4A90-99DE-848684F0505F Q35718428-442ED05C-5E5B-4612-82D1-3D2967F07E02 Q35722940-18C30C0E-F14C-4424-AEA9-52B06DA87B52 Q36181056-AA1B876B-9B88-42E8-ADAF-C4D19E17C422 Q36778227-00FC9F29-A4B1-4729-A1B9-967F133447A1 Q36827205-91B22F21-9DE5-442C-ABE1-D6622F0EE841 Q37045814-1D47C734-97DD-462C-8547-B93185EA80D7 Q37057962-FEF2420C-0A7D-4704-9E25-35942A1CA4EA Q37470003-87F94D86-F92E-43BC-80CC-B297DFC3ECF6 Q37484413-7339E219-4540-4F93-A429-BE116D5604D1 Q37601803-9E0E23EE-8D90-454E-9E2B-5CE9C21ADE68 Q37712153-8A7D81FE-A93F-430F-B9BC-CC75C9AC3525 Q38152822-FBA5C227-7887-40E7-BC4F-5D3F247D0DA0 Q38237451-3167E371-19B8-463B-BB50-5EA984916588 Q38253493-A75AA96D-FDA5-4559-8878-5B0E07158869 Q38358675-D64691A1-700B-4BE4-B642-8C4AED106180 Q38530271-297BBFB5-9AD3-47D9-AF1F-1C39E43D5642 Q38645211-8077DC61-ED49-4A0F-8E80-4DB1F50B3446 Q38721559-FE1F3D0E-F499-4282-A459-0E73A64AA26A Q40902234-ED4338FC-659B-4905-986F-64356AD09894 Q41831300-E9834B77-ECC9-4BC2-BEF1-681EF41F872B Q44001747-9AF26A22-84CA-46A0-BFBA-6B4270932237 Q44875571-0FBF52B1-66EA-478D-A1FF-F8E86EC96704 Q46650286-9149B5B9-5DC0-4424-B179-9A1F84CF7A3B Q47579647-A445384A-01F5-4FF5-ABAB-BD3C141ECE9A

P2860

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

http://www.wikidata.org/entity/Q34343729

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@ast

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@en

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@nl

type

label

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@ast

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@en

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@nl

prefLabel

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@ast

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@en

Aquaporin-4 antibody-negative ...... sensitivity-dependent entity.

@nl

P1433

Q34343729-94FEB6B2-0FC8-4676-894A-61B4C84DDD26

P1476

Q34343729-D4F5CC48-F4B9-4552-BF8F-AF399B97AA50

P2093

Q34343729-020AB4D7-6C0B-429D-89D9-C2603B897877

Q34343729-1313051A-25F0-498B-9154-0B310E0D9F4C

Q34343729-5A63C81C-CAD8-446F-BBBE-5D690F01E2BC

Q34343729-6F08F829-42A7-42A1-9B4C-BE5B10BF740F

Q34343729-78ED5A02-1495-45BB-B6BE-120F4F8D5EA4

Q34343729-80489146-EC28-482D-A1C8-4A0D4D585D5D

Q34343729-8BC04BF6-36B8-49E5-861F-214E48F46FB5

Q34343729-A1558363-5877-4167-8570-930FC7044DAA

Q34343729-B5219850-57E6-4A9A-A615-ECA02BCB8CD8

Q34343729-BA71CC17-6A63-4112-983A-14D8983C38EC

P304

Q34343729-349764F4-CEA0-4045-B38E-45A3BFB63B82

P31

Q34343729-25D8C3B9-33E0-45C0-81A2-857ACC1C8B7E

P356

Q34343729-8DD8C56A-7E51-4F0E-BF40-9015280D3F38

P407

Q34343729-E1862983-2070-4A0E-95B2-70E6CCD817E5

P433

Q34343729-D22EA4EE-F509-4F30-8B44-6637B08332C9

P478

Q34343729-F44A0375-AD9F-4CC1-B904-96D1FB3F0B3A

P50

Q34343729-5672C796-BA5D-4B27-BA99-5FEB77B4D9D3

Q34343729-8AD24486-6006-4D2F-A747-0C2C04DE0767

Q34343729-D1D17EB8-AD8B-4A4B-9356-63E3BF8F9C30

P577

Q34343729-540D15FC-349B-45F0-83FC-A39B3F1818CC

P698

Q34343729-E0608008-30F3-4D84-ADAC-B42F296D84EC

P921

Q34343729-E498F2C9-C68B-41E1-AD01-15754F866206

P356

WNL.0B013E318296E917

P1433

P1476

Aquaporin-4 antibody-negative ...... y sensitivity-dependent entity

@en

P2093

Bernard Frangoulis

http://www.w3.org/2001/XMLSchema#string

Caroline Papeix

http://www.w3.org/2001/XMLSchema#string

Christian Confavreux

http://www.w3.org/2001/XMLSchema#string

Gaëlle Cavillon

http://www.w3.org/2001/XMLSchema#string

Jérôme De Sèze

http://www.w3.org/2001/XMLSchema#string

Jérôme Honnorat

http://www.w3.org/2001/XMLSchema#string

NOMADMUS Study Group

http://www.w3.org/2001/XMLSchema#string

Nicolas Collongues

http://www.w3.org/2001/XMLSchema#string

Pascale Giraudon

http://www.w3.org/2001/XMLSchema#string

Romain Casey

http://www.w3.org/2001/XMLSchema#string

P304

2194-2200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E318296E917

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Veronique Rogemond

Raphaël Bernard-Valnet

P577

2013-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23658379

http://www.w3.org/2001/XMLSchema#string

P921